Published in Aliment Pharmacol Ther on October 01, 2000
Atypical manifestations of gastro-oesophageal reflux. J R Soc Med (2003) 1.88
Symptom evaluation in reflux disease: workshop background, processes, terminology, recommendations, and discussion outputs. Gut (2004) 1.60
Long term failure of endoscopic gastroplication (EndoCinch). Gut (2005) 1.38
Esomeprazole 40 mg provides more effective intragastric acid control than lansoprazole 30 mg, omeprazole 20 mg, pantoprazole 40 mg and rabeprazole 20 mg in patients with gastro-oesophageal reflux symptoms. Eur J Clin Pharmacol (2004) 1.36
Pharmacology of proton pump inhibitors. Curr Gastroenterol Rep (2008) 1.25
Head-to-head comparison of H2-receptor antagonists and proton pump inhibitors in the treatment of erosive esophagitis: a meta-analysis. World J Gastroenterol (2005) 1.03
Assessment of reflux symptom severity: methodological options and their attributes. Gut (2004) 1.00
Effect of esomeprazole 40 mg vs omeprazole 40 mg on 24-hour intragastric pH in patients with symptoms of gastroesophageal reflux disease. Dig Dis Sci (2002) 0.94
A review of esomeprazole in the treatment of gastroesophageal reflux disease (GERD). Ther Clin Risk Manag (2007) 0.94
Rabeprazole vs esomeprazole in non-erosive gastro-esophageal reflux disease: a randomized, double-blind study in urban Asia. World J Gastroenterol (2005) 0.94
Current perspectives in NSAID-induced gastropathy. Mediators Inflamm (2013) 0.91
The influence of demographic factors and health-related quality of life on treatment satisfaction in patients with gastroesophageal reflux disease treated with esomeprazole. Health Qual Life Outcomes (2005) 0.88
Intravenous proton pump inhibitors for peptic ulcer bleeding: Clinical benefits and limits. World J Gastrointest Endosc (2011) 0.87
Treatment of uncomplicated reflux disease. World J Gastroenterol (2005) 0.85
A systematic review of symptomatic outcomes used in oesophagitis drug therapy trials. Gut (2004) 0.84
The effectiveness of esomeprazole 40 mg in patients with persistent symptoms of gastro-oesophageal reflux disease following treatment with a full dose proton pump inhibitor. Int J Clin Pract (2008) 0.84
One week of esomeprazole triple therapy vs 1 week of omeprazole triple therapy plus 3 weeks of omeprazole for duodenal ulcer healding in Helicobacter pylori-positive patients. Dig Dis Sci (2007) 0.84
A multicenter, randomized, double-blind, 8-week comparative trial of low-dose esomeprazole (20 mg) and standard-dose omeprazole (20 mg) in patients with erosive esophagitis. Dig Dis Sci (2006) 0.83
Esomeprazole for the treatment of erosive esophagitis in children: an international, multicenter, randomized, parallel-group, double-blind (for dose) study. BMC Pediatr (2010) 0.82
Failures in a proton pump inhibitor therapeutic substitution program: lessons learned. Dig Dis Sci (2007) 0.81
The effect of Helicobacter pylori infection and eradication in patients with gastro-oesophageal reflux disease: A parallel-group, double-blind, placebo-controlled multicentre study. United European Gastroenterol J (2013) 0.81
A multicenter, randomized, double-blind, 8-week comparative trial of standard doses of esomeprazole (40 mg) and omeprazole (20 mg) for the treatment of erosive esophagitis. Dig Dis Sci (2006) 0.81
Esomeprazole tablet vs omeprazole capsule in treating erosive esophagitis. World J Gastroenterol (2005) 0.79
Heartburn severity does not predict disease severity in patients with erosive esophagitis. MedGenMed (2006) 0.79
Deracemization of a Racemic Allylic Sulfoxide Using Viedma Ripening. Cryst Growth Des (2017) 0.79
Rabeprazole: quest for the best PPI. J Gastroenterol (2002) 0.78
Proton pump inhibitor for non-erosive reflux disease: a meta-analysis. World J Gastroenterol (2013) 0.78
Differences in efficacy and safety of pharmaceutical treatments between men and women: an umbrella review. PLoS One (2010) 0.78
Pharmacologic Management of Gastroesophageal Reflux Disease. Curr Treat Options Gastroenterol (2002) 0.76
Relationship between esomeprazole dose and timing to heartburn resolution in selected patients with gastroesophageal reflux disease. Clin Exp Gastroenterol (2010) 0.76
Efficacy of esomeprazole in treating acid-related diseases in Japanese populations. Clin Exp Gastroenterol (2012) 0.76
Managing peptic ulcer and gastroesophageal reflux disease in elderly Chinese patients--focus on esomeprazole. Clin Interv Aging (2013) 0.76
Rabeprazole and esomeprazole in mild-to-moderate erosive gastroesophageal reflux disease: A comparative study of efficacy and safety. J Pharmacol Pharmacother (2011) 0.75
Comparative efficacy of esomeprazole and omeprazole: Racemate to single enantiomer switch. Daru (2015) 0.75
Management of gastroesophageal reflux disease and erosive esophagitis in pediatric patients: focus on delayed-release esomeprazole. Ther Clin Risk Manag (2010) 0.75
Gastro-oesophageal reflux disease: symptoms, erosions, and Barrett's--what is the interplay? Gut (2005) 0.75
Comparative effectiveness and acceptability of the FDA-licensed proton pump inhibitors for erosive esophagitis: A PRISMA-compliant network meta-analysis. Medicine (Baltimore) (2017) 0.75
A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med (1996) 6.05
TAP, the human homolog of Mex67p, mediates CTE-dependent RNA export from the nucleus. Mol Cell (1998) 5.85
P-selectin glycoprotein ligand-1 mediates rolling of human neutrophils on P-selectin. J Cell Biol (1995) 4.31
Colorectal cancer prevention 2000: screening recommendations of the American College of Gastroenterology. American College of Gastroenterology. Am J Gastroenterol (2000) 4.17
Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14. J Exp Med (1994) 3.61
Barrett's esophagus. A prevalent, occult complication of gastroesophageal reflux disease. Gastroenterology (1987) 3.56
Effect of fixation on the amplification of nucleic acids from paraffin-embedded material by the polymerase chain reaction. J Histochem Cytochem (1991) 3.51
Changes in annual tuberculosis notification rates between 1978/79 and 1983 for the population of Indian subcontinent ethnic origin resident in England. J Epidemiol Community Health (1986) 3.48
Treatment of depression in general practice. Br Med J (1973) 3.44
Risk factors associated with failure to receive vaccinations. Pediatrics (1979) 3.44
Evaluation of Y-chromosomal STRs: a multicenter study. Int J Legal Med (1997) 3.19
Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Lung Cancer Study Group. Oncogene (1990) 2.97
Genetic structure of natural populations of the nitrogen-fixing bacterium Rhizobium meliloti. Appl Environ Microbiol (1990) 2.84
TAP binds to the constitutive transport element (CTE) through a novel RNA-binding motif that is sufficient to promote CTE-dependent RNA export from the nucleus. EMBO J (1999) 2.83
Inflammation and intestinal metaplasia of the gastric cardia: the role of gastroesophageal reflux and H. pylori infection. Gastroenterology (1998) 2.74
Size matters: the relationship between MMP-9 expression and aortic diameter. Circulation (1997) 2.72
The DExH/D box protein HEL/UAP56 is essential for mRNA nuclear export in Drosophila. Curr Biol (2001) 2.70
p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features. Oncogene (1992) 2.64
A study of the use of antidepressant medication in general practice. Br J Psychiatry (1974) 2.63
Complexes formed by (pyrimidine)n . (purine)n DNAs on lowering the pH are three-stranded. Nucleic Acids Res (1979) 2.62
The possible significance of the ferrous oxidase activity of ceruloplasmin in normal human serum. J Biol Chem (1966) 2.58
Helicobacter pylori and gastroesophageal reflux disease: the bug may not be all bad. Am J Gastroenterol (1998) 2.51
Barrett's esophagus: a new look at surveillance based on emerging estimates of cancer risk. Am J Gastroenterol (1999) 2.50
A prospective randomized comparison of endoscopic ultrasound- and computed tomography-guided celiac plexus block for managing chronic pancreatitis pain. Am J Gastroenterol (1999) 2.40
ECG changes in a 25-year-old woman with hypocalcemia due to hypoparathyroidism. Hypocalcemia mimicking acute myocardial infarction. Chest (2000) 2.28
Depression: treatment compliance in general practice. Acta Psychiatr Scand Suppl (1981) 2.27
The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: report on the Cleveland Clinic Barrett's Esophagus Registry. Am J Gastroenterol (1999) 2.26
Effectiveness of a mailed reminder on the immunization levels of infants at high risk of failure to complete immunizations. Am J Public Health (1980) 2.16
The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease. Gastroenterology (1998) 2.14
Maintenance of sinus rhythm after electrical cardioversion of persistent atrial fibrillation; sotalol vs bisoprolol. Eur Heart J (2001) 2.06
Metabolites, pharmacodynamics, and pharmacokinetics of tamoxifen in rats and mice compared to the breast cancer patient. Drug Metab Dispos (1991) 2.04
Cognitive-behavioral therapy to reduce weight concerns improves smoking cessation outcome in weight-concerned women. J Consult Clin Psychol (2001) 1.99
Clinical implications of endoscopic ultrasound: the American Endosonography Club Study. Gastrointest Endosc (1996) 1.98
Symptoms and endoscopic findings in the diagnosis of gastroesophageal reflux disease. Scand J Gastroenterol (1987) 1.97
Reproducibility of ambulatory oesophageal pH monitoring. Gut (1988) 1.97
Surgical management of high-grade dysplasia in Barrett's esophagus. Am J Gastroenterol (1993) 1.95
Superficial adenocarcinoma of the esophagus. J Thorac Cardiovasc Surg (2001) 1.93
Chronic urticaria is not significantly associated with hepatitis C or hepatitis G infection: a case-control study. Arch Dermatol (1999) 1.93
High hepatitis C viraemia and impaired antibody response in patients coinfected with HIV. AIDS (1995) 1.93
Nanometer resolution and coherent optical dipole coupling of two individual molecules. Science (2002) 1.89
Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects. J Clin Immunol (2003) 1.86
Respiratory symptoms, lung function, and sensitisation to flour in a British bakery. Br J Ind Med (1989) 1.85
Do current dual chamber cardioverter defibrillators have advantages over conventional single chamber cardioverter defibrillators in reducing inappropriate therapies? A randomized, prospective study. J Cardiovasc Electrophysiol (2001) 1.84
The gastric cardia: fact or fiction? Am J Gastroenterol (2000) 1.84
Management of major biliary complications after laparoscopic cholecystectomy. Ann Surg (1993) 1.81
The mobilization of iron from the perfused mammalian liver by a serum copper enzyme, ferroxidase I. J Biol Chem (1971) 1.75
Long-term visual results and complications in children with aphakia. A function of cataract type. Ophthalmology (1993) 1.74
Evidence for simultaneous protein interactions between human Rad51 paralogs. J Biol Chem (2000) 1.74
Radioimmunoassay of prostaglandin F-2-alpha in peripheral venous plasma from men and women. Prostaglandins (1974) 1.71
Isolation and characterization of RAD51C, a new human member of the RAD51 family of related genes. Nucleic Acids Res (1998) 1.70
Torulopsis glabrata vaginitis: clinical aspects and susceptibility to antifungal agents. Obstet Gynecol (1990) 1.69
Beta-endorphin concentrations in the peripheral blood mononuclear cells of migraine and tension-type headache patients. Cephalalgia (1992) 1.68
Efficacy and safety of esomeprazole compared with omeprazole in GERD patients with erosive esophagitis: a randomized controlled trial. Am J Gastroenterol (2001) 1.67
Online reference database of European Y-chromosomal short tandem repeat (STR) haplotypes. Forensic Sci Int (2001) 1.67
HPV in anal squamous cell carcinoma and anal intraepithelial neoplasia (AIN). Impact of HPV analysis of anal lesions on diagnosis and prognosis. Int J Colorectal Dis (2005) 1.67
Influence of stent design on 1-year outcome after coronary stent placement: a randomized comparison of five stent types in 1,147 unselected patients. Catheter Cardiovasc Interv (2000) 1.65
Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary-artery stents in acute myocardial infarction. Circulation (1998) 1.63
Expression of mutant p53 proteins in lung cancer correlates with the class of p53 gene mutation. Oncogene (1992) 1.63
Treating the symptoms of gastro-oesophageal reflux disease: a double-blind comparison of omeprazole and cisapride. Aliment Pharmacol Ther (1997) 1.63
Ambulatory 24 hour intraesophageal pH-monitoring in the diagnosis of gastroesophageal reflux disease. Gut (1987) 1.60
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
The spectrum of spontaneous and iatrogenic esophageal injury: perforations, Mallory-Weiss tears, and hematomas. J Clin Gastroenterol (1999) 1.57
Increased risk of restenosis after placement of gold-coated stents: results of a randomized trial comparing gold-coated with uncoated steel stents in patients with coronary artery disease. Circulation (2000) 1.56
Dissociation between coronary sinus and left atrial conduction in patients with atrial fibrillation and flutter. J Cardiovasc Electrophysiol (2001) 1.56
Cloning and sequencing of Duck circovirus (DuCV). Arch Virol (2003) 1.55
Results on neutrinoless double-β decay of 76Ge from phase I of the GERDA experiment. Phys Rev Lett (2013) 1.54
A comparison of treatment of atrial fibrillation with low-energy intracardiac cardioversion and conventional external cardioversion. Eur Heart J (1997) 1.53
The severity of depression in patients treated in general practice. J R Coll Gen Pract (1977) 1.53
CagA-positive strains of Helicobacter pylori may protect against Barrett's esophagus. Am J Gastroenterol (2000) 1.53
Primary biliary cirrhosis in a patient with multiple sclerosis. Am J Gastroenterol (1989) 1.52
The Glu residue in the conserved Asn-Glu-Pro sequence of two highly divergent endo-beta-1,4-glucanases is essential for enzymatic activity. Biochem Biophys Res Commun (1990) 1.52
Differential expression of insulin-like growth factor II mRNA in human primary liver cancers, benign liver tumors, and liver cirrhosis. Cancer Res (1988) 1.51
Vancomycin during pregnancy: does it cause hearing loss or nephrotoxicity in the infant? Am J Obstet Gynecol (1989) 1.50
Endoscopic ultrasound-guided celiac plexus block for managing abdominal pain associated with chronic pancreatitis: a prospective single center experience. Am J Gastroenterol (2001) 1.50
Phosphorylation in halobacterial signal transduction. EMBO J (1995) 1.49
Comparison of angiography and intravascular ultrasound for the assessment of lumen size after coronary stent placement: impact of dilation pressures. Cathet Cardiovasc Diagn (1997) 1.49
Elastinolytic activity of human cathepsin L. Biochem J (1986) 1.48
Improving cognitive function after brain injury: the use of exercise and virtual reality. Arch Phys Med Rehabil (1999) 1.47
Transverse distance between the membrane and the agonist binding sites on the Torpedo acetylcholine receptor: a fluorescence study. Biophys J (1994) 1.45
Anesthetic implications of the child with homocystinuria. J Clin Anesth (1994) 1.45
Brush cytology vs. endoscopic biopsy for the surveillance of Barrett's esophagus. Endoscopy (2010) 1.42
Propionibacterium acnes as a cause of visually significant corneal ulcers. Cornea (2000) 1.42
Beta-endorphin levels are reduced in peripheral blood mononuclear cells of cluster headache patients. Cephalalgia (1993) 1.42
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
Possible identification of cervicogenic headache among patients with migraine: an analysis of 374 headaches. Headache (1995) 1.41
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
A further study of psychiatric out-patient services in Manchester. An operational study of general practitioner and patient expectation. Br J Psychiatry (1973) 1.39
Visual and spinal evoked potentials in diagnosis of multiple sclerosis. Br Med J (1976) 1.39
Identification of intronic point mutations as an alternative mechanism for p53 inactivation in lung cancer. J Clin Invest (1990) 1.38
Race affects healing of erosive oesophagitis in patients treated with proton pump inhibitors. Aliment Pharmacol Ther (2011) 1.38
Clinical, microbiological, and biochemical factors in recurrent bacterial vaginosis. J Clin Microbiol (1992) 1.38
Twenty-four-hour intragastric acidity and plasma gastrin during 3-month treatment with omeprazole in healthy subjects. Aliment Pharmacol Ther (1997) 1.38
Novel circovirus in mulard ducks with developmental and feathering disorders. Vet Rec (2004) 1.37
A new method for the evaluation of matches in non-recombining genomes: application to Y-chromosomal short tandem repeat (STR) haplotypes in European males. Forensic Sci Int (2000) 1.35
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
Human lung tryptase. Purification and characterization. J Biol Chem (1984) 1.33
Spontaneous and induced leukemias of myeloid origin in recombinant inbred BXH mice. J Virol (1984) 1.33
Fine-needle aspiration cytology of the thyroid. A 12-year experience with 11,000 biopsies. Clin Lab Med (1993) 1.33
Antibody directed to determinants of a Moloney virus derived MCF GP70 recognizes a thymic differentiation antigen. J Exp Med (1983) 1.32